Amylin Strikes First With Obesity Drug Deal: Biobuzz

Japanese drugmaker Takeda licenses worldwide rights to Amylin weight-loss pipeline.

Topics:  takeda   amylin   drug   
BING NEWS:
  • The new obesity drugs work, but it's a dilemma when people have to stop taking them
    There are lots of reasons people have to stop taking the new weight loss drugs: cost, shortages, side effects and life events. And the weight usually comes back, doctors say.
    05/27/2024 - 1:59 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News